BPA Call 15B41423A00000036-15B41424F00000206
- The U.S. Medical Center for Federal Prisoners in Springfield, Missouri, awarded a $11.7K firm fixed-price call against the General Services Administration Federal Supply Schedule contract to Biopool U.S., Inc. (doing business as Trinity Biotech Distribution) for two hemoglobin A1c analyzers, including all clinical materials and required service support. The award was issued on October 1, 2025, with an ultimate completion date of December 31, 2025, and utilized no set-aside designation,...
- This federal contract award is for the procurement of two hemoglobin A1c analyzers, including all associated clinical materials and required services, for the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The contract was awarded to Biopool U.S., Inc., a subsidiary of the Irish company Trinity Biotech PLC, on a firm fixed price basis under a Blanket Purchase Agreement (BPA) with the General Services Administration (GSA) Federal Supply Schedule. The contract has a ceiling...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Biopool U.S., Inc., doing business as Trinity Biotech Distribution, for the provision of Hemoglobin A1C testing services at a cost per reportable result. The contract has a ceiling value of $34,000.00 and a period of performance from July 1, 2025 to June 30, 2026. Biopool U.S., Inc. is a foreign-owned, for-profit manufacturer of medical diagnostic products and laboratory...
- This contract was awarded to Biopool US, Inc., a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment that does business as Trinity Biotech Distribution. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 on May 23, 2019 and has a potential value of $115,041.75. It is a BPA (Blanket Purchase Agreement) Call under the Critical Analyzers, Laboratory...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Biopool US, Inc., a foreign-owned for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment doing business as Trinity Biotech Distribution. The $22,230.00 contract is for the provision of glycohemoglobin analyzers, which are critical laboratory analyzers used to support quality healthcare and medical readiness programs. Biopool US, Inc....
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, by the Department of Veterans Affairs (VA). The contract is for the provision of Hemoglobin A1C testing services on a "Cost Per Reportable Results" basis, with a ceiling value of $36,771.85 and a period of performance ending on June 30, 2024. The contract is not set aside for any specific business type. Biopool U.S., Inc. is a foreign-owned,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a $100,932.15 firm fixed price definitive contract to Biopool US, Inc., doing business as Trinity Biotech Distribution, on October 1, 2018 to provide coagulation cost per test services. The contract has a completion date of September 30, 2023 and was awarded without a set-aside designation in response to a solicitation posted on August 20, 2018 seeking these products and services....
- This federal contract award is for the delivery of supplies and reagents for cost-per-test clinical laboratory services, awarded to Biopool U.S., Inc. by the U.S. Department of Veterans Affairs. The $139,301.94 firm fixed price contract is under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and has an ultimate completion date of February 23, 2022. Biopool U.S., Inc. is a subsidiary of the Ireland-based Trinity Biotech PLC, which has an established history of providing diagnostic...
- This is a firm fixed price call order awarded by the U.S. Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for glycated hemoglobin (HbA1c) clinical reference laboratory services. The call order has a ceiling value of $95,657.75 and an ultimate completion date of November 21, 2020. The contract was awarded without a set-aside on November 22, 2019 under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. Biopool U.S., Inc. has provided various...
- This federal contract award was issued by the Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for the provision of service lab reagents for glycohemoglobin testing. The contract, which has a ceiling value of $429,024.90, was awarded on a firm fixed price basis. It is a delivery order contract under the Critical Analyzers, Laboratory (FSS-66-III) master schedule. The contract does not have a set-aside designation. Through this award, Biopool U.S., Inc....
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D40089-15B41423A00000036Blanket Purchase Agreement
- 15B41423A00000036-15B41424F00000206BPA Call
Biopool U.S., Inc., operating as Trinity Biotech Distribution, received a Firm Fixed Price BPA call modification totaling $48,129.74 against the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) to support the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. The modification increases estimated funding for the FY25 period to cover invoices received during the applicable timeframe for two hemoglobin A1c analyzers and associated clinical materials and service support. The contract carries no set-aside designation and is scheduled for completion by September 30, 2025, with performance occurring at the contractor's facility in Jamestown, New York. This award represents a continuation of the contractor's ongoing relationship with the federal prison healthcare system, built on a parent BPA valued at $199,500 established October 1, 2023. Biopool U.S., Inc. is a foreign-owned subsidiary of Ireland-based Trinity Biotech PLC and serves as a key federal supplier of hemoglobin A1c testing equipment and clinical laboratory diagnostics across multiple agencies, including the Veterans Affairs system and Defense Logistics Agency. The company currently maintains approximately $58.87 million in active federal contract ceiling value across five indefinite delivery vehicles, demonstrating sustained federal reliance on the contractor's specialized laboratory diagnostic capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| A00007 | Funding Only Action | $1.3k | 1/13/26 | |
| A00006 | Funding Only Action | $6.9k | 8/20/25 | |
| A00005 | Funding Only Action | $11.3k | 7/9/25 | |
| A00004 | Funding Only Action | $6.7k | 6/6/25 | |
| A00003 | Funding Only Action | $2.1k | 5/12/25 |